0 CHECKOUT

Vertex Pharmaceuticals Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2345174
  • June 2013
  • 49 pages
  • MarketLine

Project Synopsis:

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

Vertex Pharmaceuticals Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Vertex Pharmaceuticals Incorporated since January 2007.

Scope:

– Provides intelligence on Vertex Pharmaceuticals Incorporated's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by Vertex Pharmaceuticals Incorporated and its subsidiaries since 2007.
– Information about key financial and legal advisors for Vertex Pharmaceuticals Incorporated's financial deals transactions.
– Financial deals tables and charts covering READ MORE >

Note: Product cover images may vary from those shown

COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions – Overview
--Mergers and Acquisitions – Deal reports
PARTNERSHIP
--Partnership – Overview
--Partnership – Deal reports
CAPITAL RAISING
--Capital Raising – Overview
--Capital Raising – Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

LIST OF TABLES

--Vertex Pharmaceuticals Incorporated activity by deal type – volume (trailing twelve months (TTM))
--Vertex Pharmaceuticals Incorporated M&A activity by geography (2009 -YTD2013)
--Vertex Pharmaceuticals Incorporated activity by deal type – volume (2009 -YTD2013)
--Vertex Pharmaceuticals Incorporated M&A average deal size – value ($m) (2009 -YTD2013)
--Vertex Pharmaceuticals Incorporated legal advisor ranking by value ($m)
--Vertex Pharmaceuticals Incorporated financial advisor ranking by value ($m)
--Top Deals(2009 -YTD2013)
--Vertex Pharmaceuticals Incorporated targets and partners (2009 -YTD2013)
--Vertex Pharmaceuticals Incorporated M&A volume and value trend (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated M&A activity by geography (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated partnership volume and value trend (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated partnership trend by key deal type (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated capital raising volume and value trend (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated capital raising by deal type (2009-YTD2013)

LIST OF FIGURES

--Vertex Pharmaceuticals Incorporated activity by deal type - volume (trailing twelve months (TTM))
--Vertex Pharmaceuticals Incorporated M&A activity by geography (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated activity by deal type - volume (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated M&A average deal size - value ($m)
--Vertex Pharmaceuticals Incorporated M&A volume and value trend (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated M&A activity by geography (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated partnership volume and value trend (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated partnership trend by key deal type (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated capital raising volume and value trend (2009-YTD2013)
--Vertex Pharmaceuticals Incorporated capital raising by deal type (2009-YTD2013)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.